Cyclic somatostatin

Cas No.:	38916-34-6
Chemical Name:	Cyclic somatostatin
Synonyms:	somatostatin;somatostatin gamma-irradiated*cell culture tested;Somatostatin 14;H-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys-OH (Disulfide bond);Somatostatin-14;15-28-Somatostatin-28;Somatostain Acetate;Somatostatin Acetate;SOMATOSTATIN CELL CULTURE REAGENT GAMMA-IRRADIATED;ALA-GLY-CYS-LYS-ASN-PHE-PHE-TRP-LYS-THR-PHE-THR-SER-CYS: AGCKNFFWKTFTSC DISULFIDE BRIDGE CYS3-CYS14;Aminopan;GH-RIF;growth hormone inhibiting hormone;Modustatina;Somatofalk;Somatostatina;somatotropin release inhibiting factor;SRIF;SRIF-14;SRIF-A;SS-14;Stilamin;Synthetic cyclic growth hormone release-inhibiting factor;Synthetic somatostatin-14;Cyclic somatostatin;Somatostatinum [INN-Latin];Somatostatine;BRD-K14681867-015-01-6;CHEBI:64628;Somatostatine [INN-French];SR 9357;ALA-GLY-CYS-LYS-ASN-PHE-PHE-TRP-LYS-THR-PHE-THR-SER-CYS 3,14-disulfide;CCRIS 3629;Cyclic Somatostatin;Somatostatinum;MFCD00076762;Somatostatin (pigeon);Somatostatin-14 (H-L-Ala-L-Gly-L-Cys(1)-L-Lys-L-Asn-L-Phe-L-Phe-L-Trp-L-Lys-L-Thr-L-Phe-L-Thr-L-Ser-L-Cys(1)-OH);Somatotropin release inhibiting factor;DB09099;Ala-Gly-cyclo-[Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys];Somatostatin (sheep);SOMATOSTATIN [INN];C74981;Somatostatin (rat);SOMATOSTATIN [MI];BDBM81767;AKOS015994634;CB6417646;EINECS 254-186-5;38916-34-6;CHEMBL1823872;HS-2027;Somatostatin [INN:BAN];SCHEMBL21361053;Somatostatin-14SRIF-14;Somatostatin-1;Q22075835;SOMATOSTATIN [EP MONOGRAPH];AC-8931;UNII-6E20216Q0L;Somatostatina [INN-Spanish];SOMATOSTATIN;L-alanylglycyl-L-cysteinyl-L-lysyl-L-asparaginyl-L-phenylalanyl-L-phenylalanyl-L-tryptophyl-L-lysyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-cysteine cyclic (3-14) disulfide;SOMATOSTATIN [MART.];NHXLMOGPVYXJNR-ATOGVRKGSA-N;SOMATOSTATIN [WHO-DD];Somatostatin, cyclic;SRIF 14;L-alanyl-N-[(4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R)-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-13,25,28-tribenzyl-4-carboxy-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecaazacyclooctatriacontan-37-yl]glycinamide;NCGC00167137-01;CAS_38916-34-6;Somatostatin (human);6E20216Q0L
SMILES:	O=C([C@@H](NC([C@H](CO)NC([C@H]([C@H](O)C)NC([C@H](CC1=CC=CC=C1)NC([C@H]([C@H](O)C)NC([C@H](CCCCN)NC([C@H](CC2=CNC3=C2C=CC=C3)NC([C@H](CC4=CC=CC=C4)NC([C@H](CC5=CC=CC=C5)NC([C@H](CC(N)=O)NC([C@H](CCCCN)N6)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CSSC[C@H](NC(CNC([C@@H](N)C)=O)=O)C6=O)O
Formula:	C76H104N18O19S2
M.Wt:	1637.87816
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Description:

A growth hormone-release inhibiting factor used in the treatment of severe, acute hemorrhages of gastroduodenal ulcers; regulates the endocrine system and affects neurotransmission and cell proliferation.